The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)
Open accessAbstract
Background: At present, the severity of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been a focal point. Methods: To assess the factors associated with severity and prognosis of patients infected with SARS‐CoV‐2, we retrospectively investigated the clinical, imaging and laboratory characteristics of confirmed 280 cases of novel coronavirus disease (COVID‐19) from 20 January to 20 February 2020. Results: The median age of patients in the mild group was 37.55 years, whilst that in the severe group was 63.04 years. The proportion of patients aged over 65 years in the severe group was significantly higher than that of the mild group (59.04% vs. 10.15%, P < 0.05). 85.54% of severe patients had diabetes or cardiovascular diseases, which was significantly higher than that of the mild group (51.81% vs. 7.11%, P = 0.025; 33.73% vs. 3.05%, P = 0.042). Patients in the mild group experienced earlier initiation of antiviral treatment (1.19 ± 0.45 vs. 2.65 ± 1.06 days in the severe group, P < 0.001). Our study showed that comorbidity, time from illness onset to antiviral treatment and age >=65 were three major risk factors for COVID‐19 progression, whilst comorbidity and time from illness onset to antiviral treatment were two major risk factors for COVID‐19 recovery. Conclusions: The elderly and patients with underlying diseases are more likely to experience a severe progression of COVID‐19. It is recommended that timely antiviral treatment should be initiated to slow the disease progression and improve the prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,856
Self-citationCoronavirus Disease 2019 (COVID-19): A Perspective from China
Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020) · Radiology · doi:10.1148/radiol.2020200490 · Cited by 2,070
Zhang, W., Du, R.-H., Li, B., Zheng, X.-S., Yang, X.-L., Hu, B., Wang, Y.-Y., Xiao, G.-F., Yan, B., Shi, Z.-L., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729071 · Cited by 1,799
Gilbert, M., Pullano, G., Pinotti, F., Valdano, E., Poletto, C., Boëlle, P.-Y., D'Ortenzio, E., Yazdanpanah, Y., Eholie, S. P., Altmann, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30411-6 · Cited by 1,213
COVID-19: what is next for public health?
Heymann, D. L., & Shindo, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30374-3 · Cited by 1,138
2019 Novel coronavirus: where we are and what we know
Cheng, Z. J., & Shan, J. (2020) · Infection · doi:10.1007/s15010-020-01401-y · Cited by 629
Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., Xu, W., Zhang, C., Yu, J., Jiang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa199 · Cited by 626
Self-citationLuo, H., Tang, Q.-L., Shang, Y.-X., Liang, S.-B., Yang, M., Robinson, N., & Liu, J.-P. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3192-6 · Cited by 613
Self-citationObesity and the risk and outcome of infection
Huttunen, R., & Syrjänen, J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.62 · Cited by 594
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020
Tong, Z.-D., Tang, A., Li, K.-F., Li, P., Wang, H.-L., Yi, J.-P., Zhang, Y.-L., & Yan, J.-B. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.200198 · Cited by 463
Is COVID-19 receiving ADE from other coronaviruses?
Tetro, J. A. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.006 · Cited by 434
Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19
Gostic, K., Gomez, A. C., Mummah, R. O., Kucharski, A. J., & Lloyd-Smith, J. O. (2020) · eLife · doi:10.7554/elife.55570 · Cited by 417
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China
Du, Z., Wang, L., Cauchemez, S., Xu, X., Wang, X., Cowling, B. J., & Meyers, L. A. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.200146 · Cited by 375
Jung, S.-M., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., Kobayashi, T., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020523 · Cited by 374
MacLaren, G., Fisher, D., & Brodie, D. (2020) · JAMA · doi:10.1001/jama.2020.2342 · Cited by 370
Li, J.-P. O., Lam, D. S. C., Chen, Y., & Ting, D. S. W. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-315994 · Cited by 308
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 307
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea
Kim, J. Y., Ko, J.-H., Kim, Y., Kim, Y.-J., Kim, J.-M., Chung, Y.-S., Kim, H. M., Han, M.-G., Kim, S. Y., & Chin, B. S. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e86 · Cited by 263
Obesity as a predictor for a poor prognosis of COVID-19: A systematic review
Tamara, A., & Tahapary, D. L. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.020 · Cited by 259
Open access epidemiological data from the COVID-19 outbreak
Xu, B., Kraemer, M. U. G., Xu, B., Gutierrez, B., Mekaru, S., Sewalk, K., Loskill, A., Wang, L., Cohn, E., Hill, S., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30119-5 · Cited by 250
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
Härter, G., Spinner, C. D., Roider, J., Bickel, M., Krznaric, I., Grunwald, S., Schabaz, F., Gillor, D., Postel, N., Mueller, M. C., et al. (2020) · Infection · doi:10.1007/s15010-020-01438-z · Cited by 243
Timely research papers about COVID-19 in China
Xiang, Y., Li, W., Zhang, Q., Jin, Y., Rao, W., Zeng, L., Lok, K.-I., Chow, I. H. I., Cheung, T. C. C., & Hall, B. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30375-5 · Cited by 150
Self-citationTracheostomy during SARS‐CoV ‐2 pandemic: Recommendations from the New York Head and Neck Society
Miles, B. A., Schiff, B. A., Ganly, I., Ow, T. J., Cohen, E. G., Genden, E. M., Culliney, B. E., Mehrotra, B., Savona, S. R., Wong, R. J., et al. (2020) · Head & Neck · doi:10.1002/hed.26166 · Cited by 101
Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea
Jang, J. G., Hur, J., Choi, E. Y., Hong, K. S., Lee, W., & Ahn, J. H. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e209 · Cited by 78
Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?
José, R. J. P., & Manuel, A. R. (2020) · Obesity · doi:10.1002/oby.22835 · Cited by 70
Xu, Y., Liu, H., Hu, K., & Wang, M. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.03.02 · Cited by 56
Plastic Surgery and the COVID-19 Pandemic
Öztürk, C. N., Kuruoglu, D., Öztürk, C., Rampazzo, A., & Gurunian, R. (2020) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000002443 · Cited by 50
The impact of blood glucose on community-acquired pneumonia: a retrospective cohort study
Jensen, A. V., Egelund, G. B., Andersen, S. B., Petersen, P. T., Benfield, T., Faurholt‐Jepsen, D., Rohde, G. G. U., & Ravn, P. (2017) · ERJ Open Research · doi:10.1183/23120541.00114-2016 · Cited by 34
Akirov, A., & Shimon, I. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.021 · Cited by 13
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
Preckel, B., Schultz, M. J., Vlaar, A. P. J., Hulst, A. H., Hermanides, J., de Jong, M. D., Schlack, W. S., Stevens, M. F., Weenink, R. P., & Hollmann, M. W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051495 · Cited by 12
Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity
Karlsson, E. A., Schultz‐Cherry, S., & Rosch, J. W. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00041 · Cited by 9
Cited by
Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., Soucy, J.-P. R., & Daneman, N. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.016 · Cited by 1,569
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G., Voors, A. A., Osterhaus, A. D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,081
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
Izcovich, A., Ragusa, M. A., Tortosa, F., Lavena Marzio, M. A., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241955 · Cited by 660
Metadata
- Authors
- Wu, J., Li, W., Shi, X., Chen, Z., Jiang, B., Liu, J., Wang, D., Liu, C., Meng, Y., Cui, L., Yu, J., Cao, H., & Li, L.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2020-04-20
- Volume
- 288
- Issue
- 1
- Pages
- 128-138
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W3013992432
- Cited by
- 335
- References
- 34
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.